Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

03. Dezember 2025 08:00 ET | Quelle: Bionano Genomics

Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies

SAN DIEGO, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) offering CLIA-certified laboratory developed tests (LDTs) based...
02. Dezember 2025 10:30 ET | Quelle: Research and Markets

Nanopharmaceuticals Research Report 2025: Market to Reach $104.58 Billion by 2030, Driven by Rising Chronic Disease Burden and Growing Investment in Regenerative Medicine and Nanotechnology Drugs

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Nanopharmaceuticals Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
02. Dezember 2025 10:27 ET | Quelle: Precedence Research

Oncology Market Size Worth USD 668.26 Billion by 2034

Ottawa, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The global oncology market size is expected to be worth over USD 668.26 billion by 2034, increasing from USD 279.73 billion in 2026, growing at a strong...
02. Dezember 2025 09:02 ET | Quelle: Research and Markets

Biopharmaceutical Market Trends, Opportunities, and Forecasts, 2020-2024 & 2025-2030: Growing Demand for Novel Treatments in Oncology, Autoimmune, and Genetic Disorders

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
02. Dezember 2025 08:50 ET | Quelle: Ernexa Therapeutics Inc.

Ernexa Therapeutics Strengthens Scientific and Medical Advisory Board with Appointment of Leading Oncologist Dr. Ira S. Winer, M.D., Ph.D., FACOG

CAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune...
02. Dezember 2025 08:00 ET | Quelle: Oncotelic Therapeutics, Inc.

Oncotelic and Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs

AGOURA HILLS, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% owned Joint Venture, Sapu Nano, a clinical-stage nanomedicine company, today announced new data...
02. Dezember 2025 07:00 ET | Quelle: Precedence Research

RNA Therapeutics and Vaccines Market to Soar USD 107.7 Billion by 2034 at Explosive 87% CAGR, Driven by Breakthrough RNA Technologies

Ottawa, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The global RNA therapeutics and vaccines market size is calculated at USD 0.38 billion in 2025 and is expected to reach around USD 107.7 billion by 2034,...
01. Dezember 2025 01:00 ET | Quelle: Ipsen Pharma

Ipsen mourns the passing of Henri Beaufour, a founding family Board member

PARIS, FRANCE, 1 DECEMBER 2025 - It is with great sadness that Ipsen (Euronext: IPN; ADR: IPSEY) today announces that Henri Beaufour, Ipsen Board Member and a representative of the founding family,...
28. November 2025 10:00 ET | Quelle: Precedence Research

Lead Optimization Services in Drug Discovery Market to Reach USD 10.26 Billion by 2034, Driven by Rising R&D Activity

Ottawa, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The global lead optimization services in drug discovery market size is calculated at USD 4.65 billion in 2025 and is expected to reach around USD...
27. November 2025 12:00 ET | Quelle: GENFIT S.A.

GENFIT Announces Appointment of new Chief Medical Officer

GENFIT today announced the appointment of Dr. Pejvack Motlagh, the new Chief Medical Officer of GENFIT

Vorherige Seite

Nächste Seite